Fig. 1From: Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leadsChemical structures of the E3 ubiquitin ligase inhibitors. Eight E3 ligase inhibitors tested in vitro for antimalarial activity against CQ sensitive P. falciparum D6 strain (PfD6) and CQ resistant P. falciparum W2 strain (PfW2)Back to article page